Brief: Clovis Oncology, Isotopia Announce Lutetium-177 Clinical Supply Agreement
21/09/2022 13:45
Sept 21 (Reuters) - Clovis Oncology Inc CLVS.O :
* CLOVIS ONCOLOGY AND ISOTOPIA ANNOUNCE LUTETIUM-177
CLINICAL
SUPPLY AGREEMENT
* CLOVIS ONCOLOGY INC - ISOTOPIA TO SUPPLY ITS MEDICAL
RADIOISOTOPE, LUTETIUM-177, FOR CLINICAL DEVELOPMENT OF FAP-2286
Source text for Eikon: ID:nBw3z4BJja
Further company coverage: CLVS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clovis Oncology
See all newsBrief: Clovis Oncology Inc - On April 5, 2023, Entered Into Asset Purchase Agreement With Pharma& To Sell Product Business For Upfront Payment Of $70 Million
Brief: Clovis Oncology Enters Into Financing Agreement
Brief: Clovis Oncology Inc Received Written Notice From Nasdaq That Company's Common Stock Will Be Delisted From Nasdaq
U.S. STOCKS ON THE MOVE-Nike, Faraday Future, PBF Energy
U.S. STOCKS ON THE MOVE-Natural gas, Box Inc, Weber